Rein Therapeutics's total assets for Q1 2025 were $57.63M, a decrease of -7.34% from the previous quarter. RNTX total liabilities were $52.75M for the fiscal quarter, a 576.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.